R4 Ballot #1 #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: (v3.5.0: R4 Ballot 2). #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions

11.7 11.8 Resource MedicinalProductAuthorization - Content

Biomedical Research and Regulation Work Group Maturity Level : 0   Draft Trial Use Compartments : Not linked to any defined compartments

The regulatory authorization of a medicinal product.

MedicinalProductAuthorization is a resource covering the Marketing Authorization of a Medicinal Product, from a regulatory point of view.

This resource is referenced by medicinalproduct MedicinalProduct and MedicinalProductPackaged

Structure

Name Flags Card. Type Description & Constraints doco
. . MedicinalProductAuthorization Σ D TU DomainResource The regulatory authorization of a medicinal product
Elements defined in Ancestors: id , meta , implicitRules , language , text , contained , extension , modifierExtension
. . . identifier Σ 0..1 0..* Identifier Business identifier for the marketing authorization, as assigned by a regulator
. . . subject Σ 0..1 Reference ( MedicinalProduct | MedicinalProductPackaged ) The medicinal product that is being authorized
. . . country Σ 1..* 0..* CodeableConcept The country in which the marketing authorization has been granted
. . . jurisdiction Σ 0..* CodeableConcept Jurisdiction within a country
... legalStatusOfSupply Σ 1..1 0..1 CodeableConcept The legal status of supply of the medicinal product as classified by the regulator
. . . status Σ 1..1 0..1 CodeableConcept The status of the marketing authorization
. . . statusDate Σ 1..1 0..1 dateTime The date at which the given status has become applicable
. . . restoreDate Σ 0..1 dateTime The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
. . . validityPeriod Σ 1..1 0..1 Period The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format
. . . dataExclusivityPeriod Σ 0..1 Period A period of time after authorization before generic product applicatiosn can be submitted
. . . dateOfFirstAuthorization Σ 0..1 dateTime The date when the first authorization was granted by a Medicines Regulatory Agency
. . . internationalBirthDate Σ 1..1 0..1 dateTime Date of first marketing authorization for a company's new medicinal product in any country in the World
. . . legalBasis Σ 0..1 CodeableConcept The legal framework against which this authorization is granted
. . . jurisdictionalAuthorization Σ 0..* BackboneElement Authorization in areas within a country
. . . . identifier Σ 0..* Identifier The assigned number for the marketing authorization
.... country Σ 1..1 0..1 CodeableConcept Country of authorization
. . . . jurisdiction Σ 0..1 0..* CodeableConcept Jurisdiction within a country
. . . . number legalStatusOfSupply Σ 0..1 Identifier CodeableConcept The assigned number for the marketing authorization legal status of supply in a jurisdiction or region
. . . . legalStatusOfSupply validityPeriod Σ 0..1 CodeableConcept Period The legal status start and expected end date of supply in a jurisdiction or region the authorization
. . . holder Σ 1..1 0..1 Reference ( Organization ) Marketing Authorization Holder
. . . regulator Σ 1..1 0..1 Reference ( Organization ) Medicines Regulatory Agency
. . . procedure Σ 1..1 0..1 BackboneElement The regulatory procedure for granting or amending a marketing authorization
. . . . number identifier Σ 0..1 Identifier Identifier for this procedure
. . . . type Σ 1..1 CodeableConcept Type of procedure
. . . date . date[x] Σ 0..1 Period Date of procedure
. application Σ 0..* BackboneElement Applcations submitted to obtain a marketing authorization . . . . number Σ datePeriod 1..1 Identifier A unique identifier for the specific instance of an application shall be provided in text. The application identifier/number is usually assigned by a Medicines Regulatory Agency type Σ Period 1..1 CodeableConcept The type of the application
. . . . . date dateDateTime Σ 1..1 dateTime Date that the application was made
. . . marketingStatus . application Σ 0..* MarketingStatus see procedure Marketing status of the medicinal product, in contrast Applcations submitted to obtain a marketing authorizaton authorization

doco Documentation for this format

UML Diagram ( Legend )

MedicinalProductAuthorization ( DomainResource ) Business identifier for the marketing authorization, as assigned by a regulator identifier : Identifier [0..*] The medicinal product that is being authorized subject : Reference [0..1] « MedicinalProduct | MedicinalProductPackaged » The country in which the marketing authorization has been granted country : CodeableConcept [1..*] [0..*] Jurisdiction within a country jurisdiction : CodeableConcept [0..*] The legal status of supply of the medicinal product as classified by the regulator legalStatusOfSupply : CodeableConcept [1..1] [0..1] The status of the marketing authorization status : CodeableConcept [1..1] [0..1] The date at which the given status has become applicable statusDate : dateTime [1..1] [0..1] The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored restoreDate : dateTime [0..1] The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format validityPeriod : Period [1..1] [0..1] A period of time after authorization before generic product applicatiosn can be submitted dataExclusivityPeriod : Period [0..1] The date when the first authorization was granted by a Medicines Regulatory Agency dateOfFirstAuthorization : dateTime [0..1] Date of first marketing authorization for a company's new medicinal product in any country in the World internationalBirthDate : dateTime [1..1] [0..1] The legal framework against which this authorization is granted legalBasis : CodeableConcept [0..1] Marketing Authorization Holder holder : Reference [1..1] [0..1] « Organization » Medicines Regulatory Agency regulator : Reference [1..1] [0..1] « Organization » JurisdictionalAuthorization Marketing status of The assigned number for the medicinal product, in contrast to marketing authorizaton authorization marketingStatus identifier : MarketingStatus Identifier [0..*] JurisdictionalAuthorization Country of authorization country : CodeableConcept [1..1] [0..1] Jurisdiction within a country jurisdiction : CodeableConcept [0..1] [0..*] The assigned number for the marketing authorization legal status of supply in a jurisdiction or region number legalStatusOfSupply : Identifier CodeableConcept [0..1] The legal status start and expected end date of supply in a jurisdiction or region the authorization legalStatusOfSupply validityPeriod : CodeableConcept Period [0..1] Procedure Identifier for this procedure number identifier : Identifier [0..1] Type of procedure type : CodeableConcept [1..1] Date of procedure date date[x] : Period Type [0..1] Application A unique identifier for the specific instance of an application shall be provided in text. The application identifier/number is usually assigned by a Medicines Regulatory Agency number : Identifier [1..1] The type of the application type : CodeableConcept [1..1] Date that the application was made date « Period : | dateTime [1..1] » Authorization in areas within a country jurisdictionalAuthorization [0..*] Applcations submitted to obtain a marketing authorization application [0..*] The regulatory procedure for granting or amending a marketing authorization procedure [1..1] [0..1]

XML Template

<MedicinalProductAuthorization xmlns="http://hl7.org/fhir"> doco
 <!-- from Resource: id, meta, implicitRules, and language -->
 <!-- from DomainResource: text, contained, extension, and modifierExtension -->
 <</identifier>
 <</country>
 <</legalStatusOfSupply>
 <</status>
 <

 <identifier><!-- 0..* Identifier Business identifier for the marketing authorization, as assigned by a regulator --></identifier>
 <subject><!-- 0..1 Reference(MedicinalProduct|MedicinalProductPackaged) The medicinal product that is being authorized --></subject>
 <country><!-- 0..* CodeableConcept The country in which the marketing authorization has been granted --></country>
 <jurisdiction><!-- 0..* CodeableConcept Jurisdiction within a country --></jurisdiction>
 <legalStatusOfSupply><!-- 0..1 CodeableConcept The legal status of supply of the medicinal product as classified by the regulator --></legalStatusOfSupply>
 <status><!-- 0..1 CodeableConcept The status of the marketing authorization --></status>
 <statusDate value="[dateTime]"/><!-- 0..1 The date at which the given status has become applicable -->

 <restoreDate value="[dateTime]"/><!-- 0..1 The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored -->
 <</validityPeriod>

 <validityPeriod><!-- 0..1 Period The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format --></validityPeriod>

 <dataExclusivityPeriod><!-- 0..1 Period A period of time after authorization before generic product applicatiosn can be submitted --></dataExclusivityPeriod>
 <dateOfFirstAuthorization value="[dateTime]"/><!-- 0..1 The date when the first authorization was granted by a Medicines Regulatory Agency -->
 <

 <internationalBirthDate value="[dateTime]"/><!-- 0..1 Date of first marketing authorization for a company's new medicinal product in any country in the World -->
 <legalBasis><!-- 0..1 CodeableConcept The legal framework against which this authorization is granted --></legalBasis>

 <jurisdictionalAuthorization>  <!-- 0..* Authorization in areas within a country -->
  <</country>
  <</jurisdiction>
  <</number>

  <identifier><!-- 0..* Identifier The assigned number for the marketing authorization --></identifier>
  <country><!-- 0..1 CodeableConcept Country of authorization --></country>
  <jurisdiction><!-- 0..* CodeableConcept Jurisdiction within a country --></jurisdiction>

  <legalStatusOfSupply><!-- 0..1 CodeableConcept The legal status of supply in a jurisdiction or region --></legalStatusOfSupply>
  <validityPeriod><!-- 0..1 Period The start and expected end date of the authorization --></validityPeriod>

 </jurisdictionalAuthorization>
 <</holder>
 <</regulator>
 <
  <</number>

 <holder><!-- 0..1 Reference(Organization) Marketing Authorization Holder --></holder>
 <regulator><!-- 0..1 Reference(Organization) Medicines Regulatory Agency --></regulator>
 <procedure>  <!-- 0..1 The regulatory procedure for granting or amending a marketing authorization -->
  <identifier><!-- 0..1 Identifier Identifier for this procedure --></identifier>

  <type><!-- 1..1 CodeableConcept Type of procedure --></type>
  <</date>
  <
   <</number>
   <</type>
   <
  </application>

  <date[x]><!-- 0..1 Period|dateTime Date of procedure --></date[x]>
  <application><!-- 0..* Content as for MedicinalProductAuthorization.procedure Applcations submitted to obtain a marketing authorization --></application>

 </procedure>
 <</marketingStatus>

</MedicinalProductAuthorization>

JSON Template

{doco
  "resourceType" : "MedicinalProductAuthorization",
  // from Resource: id, meta, implicitRules, and language
  // from DomainResource: text, contained, extension, and modifierExtension
  "
  "
  "
  "
  "

  "identifier" : [{ Identifier }], // Business identifier for the marketing authorization, as assigned by a regulator
  "subject" : { Reference(MedicinalProduct|MedicinalProductPackaged) }, // The medicinal product that is being authorized
  "country" : [{ CodeableConcept }], // The country in which the marketing authorization has been granted
  "jurisdiction" : [{ CodeableConcept }], // Jurisdiction within a country
  "legalStatusOfSupply" : { CodeableConcept }, // The legal status of supply of the medicinal product as classified by the regulator
  "status" : { CodeableConcept }, // The status of the marketing authorization
  "statusDate" : "<dateTime>", // The date at which the given status has become applicable

  "restoreDate" : "<dateTime>", // The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
  "

  "validityPeriod" : { Period }, // The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format

  "dataExclusivityPeriod" : { Period }, // A period of time after authorization before generic product applicatiosn can be submitted
  "dateOfFirstAuthorization" : "<dateTime>", // The date when the first authorization was granted by a Medicines Regulatory Agency
  "

  "internationalBirthDate" : "<dateTime>", // Date of first marketing authorization for a company's new medicinal product in any country in the World
  "legalBasis" : { CodeableConcept }, // The legal framework against which this authorization is granted

  "jurisdictionalAuthorization" : [{ // Authorization in areas within a country
    "
    "
    "
    "

    "identifier" : [{ Identifier }], // The assigned number for the marketing authorization
    "country" : { CodeableConcept }, // Country of authorization
    "jurisdiction" : [{ CodeableConcept }], // Jurisdiction within a country
    "legalStatusOfSupply" : { CodeableConcept }, // The legal status of supply in a jurisdiction or region
    "validityPeriod" : { Period } // The start and expected end date of the authorization

  }],
  "
  "
  "
    "

  "holder" : { Reference(Organization) }, // Marketing Authorization Holder
  "regulator" : { Reference(Organization) }, // Medicines Regulatory Agency
  "procedure" : { // The regulatory procedure for granting or amending a marketing authorization
    "identifier" : { Identifier }, // Identifier for this procedure

    "type" : { CodeableConcept }, // R!  Type of procedure
    "
    "
      "
      "
      "
    }]
  },
  "

    // date[x]: Date of procedure. One of these 2:
    "datePeriod" : { Period },
    "dateDateTime" : "<dateTime>",
    "application" : [{ Content as for MedicinalProductAuthorization.procedure }] // Applcations submitted to obtain a marketing authorization
  }

}

Turtle Template

@prefix fhir: <http://hl7.org/fhir/> .doco


[ a fhir:MedicinalProductAuthorization;
  fhir:nodeRole fhir:treeRoot; # if this is the parser root

  # from Resource: .id, .meta, .implicitRules, and .language
  # from DomainResource: .text, .contained, .extension, and .modifierExtension
  fhir:
  fhir:
  fhir:
  fhir:
  fhir:

  fhir:MedicinalProductAuthorization.identifier [ Identifier ], ... ; # 0..* Business identifier for the marketing authorization, as assigned by a regulator
  fhir:MedicinalProductAuthorization.subject [ Reference(MedicinalProduct|MedicinalProductPackaged) ]; # 0..1 The medicinal product that is being authorized
  fhir:MedicinalProductAuthorization.country [ CodeableConcept ], ... ; # 0..* The country in which the marketing authorization has been granted
  fhir:MedicinalProductAuthorization.jurisdiction [ CodeableConcept ], ... ; # 0..* Jurisdiction within a country
  fhir:MedicinalProductAuthorization.legalStatusOfSupply [ CodeableConcept ]; # 0..1 The legal status of supply of the medicinal product as classified by the regulator
  fhir:MedicinalProductAuthorization.status [ CodeableConcept ]; # 0..1 The status of the marketing authorization
  fhir:MedicinalProductAuthorization.statusDate [ dateTime ]; # 0..1 The date at which the given status has become applicable

  fhir:MedicinalProductAuthorization.restoreDate [ dateTime ]; # 0..1 The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
  fhir:

  fhir:MedicinalProductAuthorization.validityPeriod [ Period ]; # 0..1 The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format

  fhir:MedicinalProductAuthorization.dataExclusivityPeriod [ Period ]; # 0..1 A period of time after authorization before generic product applicatiosn can be submitted
  fhir:MedicinalProductAuthorization.dateOfFirstAuthorization [ dateTime ]; # 0..1 The date when the first authorization was granted by a Medicines Regulatory Agency
  fhir:

  fhir:MedicinalProductAuthorization.internationalBirthDate [ dateTime ]; # 0..1 Date of first marketing authorization for a company's new medicinal product in any country in the World
  fhir:MedicinalProductAuthorization.legalBasis [ CodeableConcept ]; # 0..1 The legal framework against which this authorization is granted

  fhir:MedicinalProductAuthorization.jurisdictionalAuthorization [ # 0..* Authorization in areas within a country
    fhir:
    fhir:
    fhir:

    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.identifier [ Identifier ], ... ; # 0..* The assigned number for the marketing authorization
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.country [ CodeableConcept ]; # 0..1 Country of authorization
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.jurisdiction [ CodeableConcept ], ... ; # 0..* Jurisdiction within a country

    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.legalStatusOfSupply [ CodeableConcept ]; # 0..1 The legal status of supply in a jurisdiction or region
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.validityPeriod [ Period ]; # 0..1 The start and expected end date of the authorization

  ], ...;
  fhir:
  fhir:
  fhir:
    fhir:

  fhir:MedicinalProductAuthorization.holder [ Reference(Organization) ]; # 0..1 Marketing Authorization Holder
  fhir:MedicinalProductAuthorization.regulator [ Reference(Organization) ]; # 0..1 Medicines Regulatory Agency
  fhir:MedicinalProductAuthorization.procedure [ # 0..1 The regulatory procedure for granting or amending a marketing authorization
    fhir:MedicinalProductAuthorization.procedure.identifier [ Identifier ]; # 0..1 Identifier for this procedure

    fhir:MedicinalProductAuthorization.procedure.type [ CodeableConcept ]; # 1..1 Type of procedure
    fhir:
    fhir:
      fhir:
      fhir:
      fhir:
    ], ...;

    # MedicinalProductAuthorization.procedure.date[x] : 0..1 Date of procedure. One of these 2
      fhir:MedicinalProductAuthorization.procedure.datePeriod [ Period ]
      fhir:MedicinalProductAuthorization.procedure.dateDateTime [ dateTime ]
    fhir:MedicinalProductAuthorization.procedure.application [ See MedicinalProductAuthorization.procedure ], ... ; # 0..* Applcations submitted to obtain a marketing authorization

  ];
  fhir:

]

Changes since R3

This resource did not exist in Release 2

This analysis is available as XML or JSON .

See R3 <--> R4 Conversion Maps (status = Not Mapped)

Structure

Name Flags Card. Type Description & Constraints doco
. . MedicinalProductAuthorization Σ D TU DomainResource The regulatory authorization of a medicinal product
Elements defined in Ancestors: id , meta , implicitRules , language , text , contained , extension , modifierExtension
. . . identifier Σ 0..1 0..* Identifier Business identifier for the marketing authorization, as assigned by a regulator
. . . subject Σ 0..1 Reference ( MedicinalProduct | MedicinalProductPackaged ) The medicinal product that is being authorized
. . . country Σ 1..* 0..* CodeableConcept The country in which the marketing authorization has been granted
. . . jurisdiction Σ 0..* CodeableConcept Jurisdiction within a country
... legalStatusOfSupply Σ 1..1 0..1 CodeableConcept The legal status of supply of the medicinal product as classified by the regulator
. . . status Σ 1..1 0..1 CodeableConcept The status of the marketing authorization
. . . statusDate Σ 1..1 0..1 dateTime The date at which the given status has become applicable
. . . restoreDate Σ 0..1 dateTime The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
. . . validityPeriod Σ 1..1 0..1 Period The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format
. . . dataExclusivityPeriod Σ 0..1 Period A period of time after authorization before generic product applicatiosn can be submitted
. . . dateOfFirstAuthorization Σ 0..1 dateTime The date when the first authorization was granted by a Medicines Regulatory Agency
. . . internationalBirthDate Σ 1..1 0..1 dateTime Date of first marketing authorization for a company's new medicinal product in any country in the World
. . . legalBasis Σ 0..1 CodeableConcept The legal framework against which this authorization is granted
. . . jurisdictionalAuthorization Σ 0..* BackboneElement Authorization in areas within a country
. . . . identifier Σ 0..* Identifier The assigned number for the marketing authorization
.... country Σ 1..1 0..1 CodeableConcept Country of authorization
. . . . jurisdiction Σ 0..1 0..* CodeableConcept Jurisdiction within a country
. . . . number legalStatusOfSupply Σ 0..1 Identifier CodeableConcept The assigned number for the marketing authorization legal status of supply in a jurisdiction or region
. . . . legalStatusOfSupply validityPeriod Σ 0..1 CodeableConcept Period The legal status start and expected end date of supply in a jurisdiction or region the authorization
. . . holder Σ 1..1 0..1 Reference ( Organization ) Marketing Authorization Holder
. . . regulator Σ 1..1 0..1 Reference ( Organization ) Medicines Regulatory Agency
. . . procedure Σ 1..1 0..1 BackboneElement The regulatory procedure for granting or amending a marketing authorization
. . . . number identifier Σ 0..1 Identifier Identifier for this procedure
. . . . type Σ 1..1 CodeableConcept Type of procedure
. . . date . date[x] Σ 0..1 Period Date of procedure
. application Σ 0..* BackboneElement Applcations submitted to obtain a marketing authorization . . . . number Σ datePeriod 1..1 Identifier A unique identifier for the specific instance of an application shall be provided in text. The application identifier/number is usually assigned by a Medicines Regulatory Agency type Σ Period 1..1 CodeableConcept The type of the application
. . . . . date dateDateTime Σ 1..1 dateTime Date that the application was made
. . . marketingStatus . application Σ 0..* MarketingStatus see procedure Marketing status of the medicinal product, in contrast Applcations submitted to obtain a marketing authorizaton authorization

doco Documentation for this format

UML Diagram ( Legend )

MedicinalProductAuthorization ( DomainResource ) Business identifier for the marketing authorization, as assigned by a regulator identifier : Identifier [0..*] The medicinal product that is being authorized subject : Reference [0..1] « MedicinalProduct | MedicinalProductPackaged » The country in which the marketing authorization has been granted country : CodeableConcept [1..*] [0..*] Jurisdiction within a country jurisdiction : CodeableConcept [0..*] The legal status of supply of the medicinal product as classified by the regulator legalStatusOfSupply : CodeableConcept [1..1] [0..1] The status of the marketing authorization status : CodeableConcept [1..1] [0..1] The date at which the given status has become applicable statusDate : dateTime [1..1] [0..1] The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored restoreDate : dateTime [0..1] The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format validityPeriod : Period [1..1] [0..1] A period of time after authorization before generic product applicatiosn can be submitted dataExclusivityPeriod : Period [0..1] The date when the first authorization was granted by a Medicines Regulatory Agency dateOfFirstAuthorization : dateTime [0..1] Date of first marketing authorization for a company's new medicinal product in any country in the World internationalBirthDate : dateTime [1..1] [0..1] The legal framework against which this authorization is granted legalBasis : CodeableConcept [0..1] Marketing Authorization Holder holder : Reference [1..1] [0..1] « Organization » Medicines Regulatory Agency regulator : Reference [1..1] [0..1] « Organization » JurisdictionalAuthorization Marketing status of The assigned number for the medicinal product, in contrast to marketing authorizaton authorization marketingStatus identifier : MarketingStatus Identifier [0..*] JurisdictionalAuthorization Country of authorization country : CodeableConcept [1..1] [0..1] Jurisdiction within a country jurisdiction : CodeableConcept [0..1] [0..*] The assigned number for the marketing authorization legal status of supply in a jurisdiction or region number legalStatusOfSupply : Identifier CodeableConcept [0..1] The legal status start and expected end date of supply in a jurisdiction or region the authorization legalStatusOfSupply validityPeriod : CodeableConcept Period [0..1] Procedure Identifier for this procedure number identifier : Identifier [0..1] Type of procedure type : CodeableConcept [1..1] Date of procedure date date[x] : Period Type [0..1] Application A unique identifier for the specific instance of an application shall be provided in text. The application identifier/number is usually assigned by a Medicines Regulatory Agency number : Identifier [1..1] The type of the application type : CodeableConcept [1..1] Date that the application was made date « Period : | dateTime [1..1] » Authorization in areas within a country jurisdictionalAuthorization [0..*] Applcations submitted to obtain a marketing authorization application [0..*] The regulatory procedure for granting or amending a marketing authorization procedure [1..1] [0..1]

XML Template

<MedicinalProductAuthorization xmlns="http://hl7.org/fhir"> doco
 <!-- from Resource: id, meta, implicitRules, and language -->
 <!-- from DomainResource: text, contained, extension, and modifierExtension -->
 <</identifier>
 <</country>
 <</legalStatusOfSupply>
 <</status>
 <

 <identifier><!-- 0..* Identifier Business identifier for the marketing authorization, as assigned by a regulator --></identifier>
 <subject><!-- 0..1 Reference(MedicinalProduct|MedicinalProductPackaged) The medicinal product that is being authorized --></subject>
 <country><!-- 0..* CodeableConcept The country in which the marketing authorization has been granted --></country>
 <jurisdiction><!-- 0..* CodeableConcept Jurisdiction within a country --></jurisdiction>
 <legalStatusOfSupply><!-- 0..1 CodeableConcept The legal status of supply of the medicinal product as classified by the regulator --></legalStatusOfSupply>
 <status><!-- 0..1 CodeableConcept The status of the marketing authorization --></status>
 <statusDate value="[dateTime]"/><!-- 0..1 The date at which the given status has become applicable -->

 <restoreDate value="[dateTime]"/><!-- 0..1 The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored -->
 <</validityPeriod>

 <validityPeriod><!-- 0..1 Period The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format --></validityPeriod>

 <dataExclusivityPeriod><!-- 0..1 Period A period of time after authorization before generic product applicatiosn can be submitted --></dataExclusivityPeriod>
 <dateOfFirstAuthorization value="[dateTime]"/><!-- 0..1 The date when the first authorization was granted by a Medicines Regulatory Agency -->
 <

 <internationalBirthDate value="[dateTime]"/><!-- 0..1 Date of first marketing authorization for a company's new medicinal product in any country in the World -->
 <legalBasis><!-- 0..1 CodeableConcept The legal framework against which this authorization is granted --></legalBasis>

 <jurisdictionalAuthorization>  <!-- 0..* Authorization in areas within a country -->
  <</country>
  <</jurisdiction>
  <</number>

  <identifier><!-- 0..* Identifier The assigned number for the marketing authorization --></identifier>
  <country><!-- 0..1 CodeableConcept Country of authorization --></country>
  <jurisdiction><!-- 0..* CodeableConcept Jurisdiction within a country --></jurisdiction>

  <legalStatusOfSupply><!-- 0..1 CodeableConcept The legal status of supply in a jurisdiction or region --></legalStatusOfSupply>
  <validityPeriod><!-- 0..1 Period The start and expected end date of the authorization --></validityPeriod>

 </jurisdictionalAuthorization>
 <</holder>
 <</regulator>
 <
  <</number>

 <holder><!-- 0..1 Reference(Organization) Marketing Authorization Holder --></holder>
 <regulator><!-- 0..1 Reference(Organization) Medicines Regulatory Agency --></regulator>
 <procedure>  <!-- 0..1 The regulatory procedure for granting or amending a marketing authorization -->
  <identifier><!-- 0..1 Identifier Identifier for this procedure --></identifier>

  <type><!-- 1..1 CodeableConcept Type of procedure --></type>
  <</date>
  <
   <</number>
   <</type>
   <
  </application>

  <date[x]><!-- 0..1 Period|dateTime Date of procedure --></date[x]>
  <application><!-- 0..* Content as for MedicinalProductAuthorization.procedure Applcations submitted to obtain a marketing authorization --></application>

 </procedure>
 <</marketingStatus>

</MedicinalProductAuthorization>

JSON Template

{doco
  "resourceType" : "MedicinalProductAuthorization",
  // from Resource: id, meta, implicitRules, and language
  // from DomainResource: text, contained, extension, and modifierExtension
  "
  "
  "
  "
  "

  "identifier" : [{ Identifier }], // Business identifier for the marketing authorization, as assigned by a regulator
  "subject" : { Reference(MedicinalProduct|MedicinalProductPackaged) }, // The medicinal product that is being authorized
  "country" : [{ CodeableConcept }], // The country in which the marketing authorization has been granted
  "jurisdiction" : [{ CodeableConcept }], // Jurisdiction within a country
  "legalStatusOfSupply" : { CodeableConcept }, // The legal status of supply of the medicinal product as classified by the regulator
  "status" : { CodeableConcept }, // The status of the marketing authorization
  "statusDate" : "<dateTime>", // The date at which the given status has become applicable

  "restoreDate" : "<dateTime>", // The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
  "

  "validityPeriod" : { Period }, // The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format

  "dataExclusivityPeriod" : { Period }, // A period of time after authorization before generic product applicatiosn can be submitted
  "dateOfFirstAuthorization" : "<dateTime>", // The date when the first authorization was granted by a Medicines Regulatory Agency
  "

  "internationalBirthDate" : "<dateTime>", // Date of first marketing authorization for a company's new medicinal product in any country in the World
  "legalBasis" : { CodeableConcept }, // The legal framework against which this authorization is granted

  "jurisdictionalAuthorization" : [{ // Authorization in areas within a country
    "
    "
    "
    "

    "identifier" : [{ Identifier }], // The assigned number for the marketing authorization
    "country" : { CodeableConcept }, // Country of authorization
    "jurisdiction" : [{ CodeableConcept }], // Jurisdiction within a country
    "legalStatusOfSupply" : { CodeableConcept }, // The legal status of supply in a jurisdiction or region
    "validityPeriod" : { Period } // The start and expected end date of the authorization

  }],
  "
  "
  "
    "

  "holder" : { Reference(Organization) }, // Marketing Authorization Holder
  "regulator" : { Reference(Organization) }, // Medicines Regulatory Agency
  "procedure" : { // The regulatory procedure for granting or amending a marketing authorization
    "identifier" : { Identifier }, // Identifier for this procedure

    "type" : { CodeableConcept }, // R!  Type of procedure
    "
    "
      "
      "
      "
    }]
  },
  "

    // date[x]: Date of procedure. One of these 2:
    "datePeriod" : { Period },
    "dateDateTime" : "<dateTime>",
    "application" : [{ Content as for MedicinalProductAuthorization.procedure }] // Applcations submitted to obtain a marketing authorization
  }

}

Turtle Template

@prefix fhir: <http://hl7.org/fhir/> .doco


[ a fhir:MedicinalProductAuthorization;
  fhir:nodeRole fhir:treeRoot; # if this is the parser root

  # from Resource: .id, .meta, .implicitRules, and .language
  # from DomainResource: .text, .contained, .extension, and .modifierExtension
  fhir:
  fhir:
  fhir:
  fhir:
  fhir:

  fhir:MedicinalProductAuthorization.identifier [ Identifier ], ... ; # 0..* Business identifier for the marketing authorization, as assigned by a regulator
  fhir:MedicinalProductAuthorization.subject [ Reference(MedicinalProduct|MedicinalProductPackaged) ]; # 0..1 The medicinal product that is being authorized
  fhir:MedicinalProductAuthorization.country [ CodeableConcept ], ... ; # 0..* The country in which the marketing authorization has been granted
  fhir:MedicinalProductAuthorization.jurisdiction [ CodeableConcept ], ... ; # 0..* Jurisdiction within a country
  fhir:MedicinalProductAuthorization.legalStatusOfSupply [ CodeableConcept ]; # 0..1 The legal status of supply of the medicinal product as classified by the regulator
  fhir:MedicinalProductAuthorization.status [ CodeableConcept ]; # 0..1 The status of the marketing authorization
  fhir:MedicinalProductAuthorization.statusDate [ dateTime ]; # 0..1 The date at which the given status has become applicable

  fhir:MedicinalProductAuthorization.restoreDate [ dateTime ]; # 0..1 The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored
  fhir:

  fhir:MedicinalProductAuthorization.validityPeriod [ Period ]; # 0..1 The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format

  fhir:MedicinalProductAuthorization.dataExclusivityPeriod [ Period ]; # 0..1 A period of time after authorization before generic product applicatiosn can be submitted
  fhir:MedicinalProductAuthorization.dateOfFirstAuthorization [ dateTime ]; # 0..1 The date when the first authorization was granted by a Medicines Regulatory Agency
  fhir:

  fhir:MedicinalProductAuthorization.internationalBirthDate [ dateTime ]; # 0..1 Date of first marketing authorization for a company's new medicinal product in any country in the World
  fhir:MedicinalProductAuthorization.legalBasis [ CodeableConcept ]; # 0..1 The legal framework against which this authorization is granted

  fhir:MedicinalProductAuthorization.jurisdictionalAuthorization [ # 0..* Authorization in areas within a country
    fhir:
    fhir:
    fhir:

    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.identifier [ Identifier ], ... ; # 0..* The assigned number for the marketing authorization
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.country [ CodeableConcept ]; # 0..1 Country of authorization
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.jurisdiction [ CodeableConcept ], ... ; # 0..* Jurisdiction within a country

    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.legalStatusOfSupply [ CodeableConcept ]; # 0..1 The legal status of supply in a jurisdiction or region
    fhir:MedicinalProductAuthorization.jurisdictionalAuthorization.validityPeriod [ Period ]; # 0..1 The start and expected end date of the authorization

  ], ...;
  fhir:
  fhir:
  fhir:
    fhir:

  fhir:MedicinalProductAuthorization.holder [ Reference(Organization) ]; # 0..1 Marketing Authorization Holder
  fhir:MedicinalProductAuthorization.regulator [ Reference(Organization) ]; # 0..1 Medicines Regulatory Agency
  fhir:MedicinalProductAuthorization.procedure [ # 0..1 The regulatory procedure for granting or amending a marketing authorization
    fhir:MedicinalProductAuthorization.procedure.identifier [ Identifier ]; # 0..1 Identifier for this procedure

    fhir:MedicinalProductAuthorization.procedure.type [ CodeableConcept ]; # 1..1 Type of procedure
    fhir:
    fhir:
      fhir:
      fhir:
      fhir:
    ], ...;

    # MedicinalProductAuthorization.procedure.date[x] : 0..1 Date of procedure. One of these 2
      fhir:MedicinalProductAuthorization.procedure.datePeriod [ Period ]
      fhir:MedicinalProductAuthorization.procedure.dateDateTime [ dateTime ]
    fhir:MedicinalProductAuthorization.procedure.application [ See MedicinalProductAuthorization.procedure ], ... ; # 0..* Applcations submitted to obtain a marketing authorization

  ];
  fhir:

]

Changes since DSTU2 Release 3

This resource did not exist in Release 2

This analysis is available as XML or JSON .

See R3 <--> R4 Conversion Maps (status = Not Mapped)

 

Alternate See the Profiles & Extensions and the alternate definitions: Master Definition XML + JSON , XML Schema / Schematron + JSON Schema , ShEx (for Turtle ) + see the extensions & the dependency analysis

Search parameters for this resource. The common parameters also apply. See Searching for more information about searching in REST, messaging, and services.

Name Type Description Expression In Common
subject reference The item that is being authorized MedicinalProductAuthorization.subject
( MedicinalProductPackaged , MedicinalProduct )